天普人工智能
TEM
64.72
-6.41
-9.01%
天普人工智能
US · TEM
#1138 按市值排名
上市于 2024
64.72
-6.41
-9.01%
实时 - 追踪5344个代码 - 心跳于81秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 机构持股总比例下降了5.4个百分点。
机构持股
- 机构持股比例
- 59.76% -5.36pp
- 机构数量
- 569
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund40.67%
Individual/Insider34.65%
Public Company10.54%
Hedge Fund2.99%
Private Company2.91%
Family Office/Trust0.94%
Government Pension Fund0.77%
Sovereign Wealth Fund0.54%
VC/PE Fund0.15%
Insurance Company0.17%
Other5.81%
主要股东 截至 2026-09-22
Eric Lefkofsky
22.52% · 40.64M 股
Bradley Keywell
7.12% · 12.85M 股
ARK Investment Management LLC
5.55% · 10.02M 股
BlackRock
4.60% · 8.29M 股
Baillie Gifford
4.54% · 8.19M 股
Kimberly Keywell
4.47% · 8.06M 股
Vanguard Capital Management, LLC
3.14% · 5.66M 股
SoftBank Group Corp.
3.00% · 5.41M 股
Vanguard Portfolio Management, LLC
2.72% · 4.91M 股
Amova Asset Management
2.27% · 4.09M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 10次买入 · 40次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Eric Lefkofsky | Co-Founder, CEO, President & Chairman | 22.52% |
| Bradley Keywell | Co-Founder | 7.12% |
| Kimberly Keywell | -- | 4.47% |
| Ryan Fukushima | Chief Operating Officer | 0.34% |
| Peter Barris | Independent Director | 0.06% |
| Theodore Leonsis | Independent Director | 0.04% |
| Andrew Polovin | General Counsel | 0.02% |
| Erik Phelps | Executive VP, Assistant Secretary, Chief Administrative & Legal Officer | 0.01% |
| Tom Schoenherr | CEO of Ambry Genetics | 0.01% |
| Ryan Bartolucci | Chief Accounting Officer | 0.01% |
| Eric Belcher | Independent Director | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-24 | Tom Schoenherr | CEO of Ambry Genetics | Automatic Disposition | -10,281 | $85.00 |
| 2026-09-21 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Automatic Disposition | -242,500 | $76.57–78.86 |
| 2026-09-16 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Automatic Disposition | -192,500 | $80.52–81.09 |
| 2026-09-16 | Ryan Bartolucci | Chief Accounting Officer | Automatic Disposition | -7,062 | $75.00 |
| 2026-09-16 | Andrew Polovin | General Counsel | Automatic Disposition | -2,951 | $75.00 |
| 2026-09-15 | Ryan Fukushima | Chief Operating Officer | Automatic Disposition | -700 | $70.00 |
| 2026-08-31 | David Epstein | Independent Director | Automatic Disposition | -250 | $65.55 |
| 2026-08-31 | Jennifer Doudna | Independent Director | Automatic Disposition | -676 | $65.55 |
| 2026-08-31 | Ryan Fukushima | Chief Operating Officer | Automatic Disposition | -30,846 | $62.12–64.63 |
| 2026-08-27 | Nadja West | Independent Director | Automatic Disposition | -3,000 | $69.00 |
| 2026-08-20 | Tom Schoenherr | CEO of Ambry Genetics | Open Market Disposition | -2,694 | $70.00 |
| 2026-08-20 | Ryan Fukushima | Chief Operating Officer | Open Market Disposition | -14,286 | $70.00 |
| 2026-08-18 | Tom Schoenherr | CEO of Ambry Genetics | Automatic Disposition | -8,082 | $55.97–61.23 |
| 2026-08-18 | Andrew Polovin | General Counsel | Automatic Disposition | -7,927 | $56.00 |
| 2026-08-18 | James Rogers | Chief Financial Officer | Automatic Disposition | -26,313 | $60.00 |
| 2026-08-17 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Open Market Disposition | -132,591 | $49.61 |
| 2026-08-17 | Tom Schoenherr | CEO of Ambry Genetics | Open Market Disposition | -9,232 | $49.61 |
| 2026-08-17 | Ryan Fukushima | Chief Operating Officer | Open Market Disposition | -41,095 | $49.61 |
| 2026-08-17 | Ryan Bartolucci | Chief Accounting Officer | Open Market Disposition | -6,175 | $49.61 |
| 2026-08-17 | Andrew Polovin | General Counsel | Open Market Disposition | -22,148 | $49.61 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:18 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
天普人工智能 讨论区 0 条评论